Bladder-preserving concurrent radiotherapy and low-dose gemcitabine for muscle-invasive bladder urothelial carcinoma: Pathological complete response and safety

Dongli Ruan; Xiulong Ma; Zhibin Li; Huilong Wang; Yi Huang; Wenjing Meng

doi:10.1016/j.jrras.2026.102550

Q1 2026

Bladder-preserving concurrent radiotherapy and low-dose gemcitabine for muscle-invasive bladder urothelial carcinoma: Pathological complete response and safety

Dongli Ruan · Xiulong Ma · Zhibin Li · Huilong Wang · Yi Huang · Wenjing Meng

10.1016/j.jrras.2026.102550 389 Views 0 Citations

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Dongli, R., Xiulong, M., Zhibin, L., Huilong, W., Yi, H., Wenjing, M. (2026). Bladder-preserving concurrent radiotherapy and low-dose gemcitabine for muscle-invasive bladder urothelial carcinoma: Pathological complete response and safety. Journal of Radiation Research and Applied Sciences. https://doi.org/10.1016/j.jrras.2026.102550